Interestingly, repression of Mat1a with the induction of Mat2a, which is usually only expressed during liver development, is characteristic of NAFLD and aggressive hepatocellular carcinoma progression68–72. The gene discussed is MAT1A; the disease is metabolic dysfunction-associated steatotic liver disease.